Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Regulatory T-cell expansion refers to the increase in number and/or suppressive function of regulatory T cells (Tregs), a subset of T cells crucial for maintaining immune homeostasis and preventing autoimmunity. This process involves complex molecular pathways and cytokine signaling (e.g., IL-2, TGF-β). Therapeutic manipulation of Treg expansion holds promise for treating autoimmune diseases and promoting transplant tolerance, but requires careful consideration of potential safety concerns related to over-suppression of the immune system.
Varies depending on the specific intervention used to promote Treg expansion. Examples include: IL-2 stimulation leading to STAT5 activation; TGF-β signaling promoting FOXP3 expression; modulation of metabolic pathways to favor Treg survival and function.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Regulatory T-cell expansion.